-+ 0.00%
-+ 0.00%
-+ 0.00%

This Pfizer Analyst Begins Coverage On A Bearish Note; Here Are Top 5 Initiations For Friday

Benzinga·02/20/2026 16:49:37
Listen to the news

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

  • Baird analyst David Koning initiated coverage on Affirm Holdings Inc (NASDAQ:AFRM) with a Neutral rating and announced a price target of $55. Affirm shares closed at $51.82 on Thursday. See how other analysts view this stock.
  • Piper Sandler analyst Biren Amin initiated coverage on OKYO Pharma Ltd (NASDAQ:OKYO) with an Overweight rating and announced a price target of $7. OKYO Pharma shares closed at $1.76 on Thursday. See how other analysts view this stock.
  • Cantor Fitzgerald analyst Andres Sheppard initiated coverage on Satellogic Inc (NASDAQ:SATL) with an Overweight rating and announced a price target of $7. Satellogic shares closed at $3.26 on Thursday. See how other analysts view this stock.
  • Barclays analyst Emily Field initiated coverage on Pfizer Inc. (NYSE:PFE) with an Underweight rating and announced a price target of $25. Pfizer shares closed at $26.86 on Thursday. See how other analysts view this stock.
  • Barclays analyst Emily Field initiated coverage on Bristol-Myers Squibb Company (NYSE:BMY) with an Overweight rating and announced a price target of $75. Bristol-Myers Squibb shares closed at $60.30 on Thursday. See how other analysts view this stock.

Considering buying SATL stock? Here’s what analysts think:

Photo via Shutterstock